Ischemia-modified albumin: is it a promising marker in acute coronary syndrome?

Background: Acute coronary syndrome (ACS) is a type of coronary heart disease (CHD), which is responsible for one-third of total deaths in people older than 35 years. Even though cardiac troponin is the gold standard for myocardial necrosis it is blind for ischemia without necrosis. Studies demonstrate that Ischaemia Modified Albumin (IMA) is more sensitive in diagnosing ischemic chest pain compared to cardiac troponin T and electrocardiogram, and its combination with these tests significantly increases the sensitivity for diagnosing unstable angina, non-ST-elevation myocardial infarction (NSTEMI), or ST-elevation myocardial infarction (STEMI), with high positive and negative predictive values, making it a valuable tool for ruling out ACS in patients with inconclusive diagnoses in the emergency department.

Unravelling the impact of climate change on honey bees: An ensemble modelling approach to predict shifts in habitat suitability in Queensland, Australia.

Honey bees play a vital role in providing essential ecosystem services and contributing to global agriculture. However, the potential effect of climate change on honey bee distribution is still not well understood. This study aims to identify the most influential bioclimatic and environmental variables, assess their impact on honey bee distribution, and predict future distribution.

Evidence-based intrapartum care during vaginal births: Direct observations in a tertiary care hospital in Central Sri Lanka.

Background: Evidence-based practice (EBP) is an effective approach to improve maternal and newborn outcomes at birth.

Objective: This study aimed to assess the current intrapartum practices of a tertiary care hospital in Central Province, Sri Lanka, during vaginal births. The benchmark for this assessment was the World Health Organisation's (WHO) recommendations on intrapartum care for a positive childbirth experience.

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy.

Background: In people living with HIV-HBV, liver fibrosis progression can occur even with suppressive antiretroviral therapy (ART). We investigated the relationship between liver fibrosis and biomarkers of inflammation, apoptosis, and microbial translocation.

Methods: In this observational cohort study adults living with HIV-HBV already on effective ART were recruited in Australia and Thailand and followed for 3 years including 6 monthly clinical review and blood tests and annual transient elastography.